Meningococcal polysaccharide vaccine groups ACYW135 - Beijing Tiantan Biological

Drug Profile

Meningococcal polysaccharide vaccine groups ACYW135 - Beijing Tiantan Biological

Alternative Names: Meningococcal ACWY Vaccine; Meningococcal vaccine groups A, C, W135 and Y polysaccharide

Latest Information Update: 29 Aug 2016

Price : $50

At a glance

  • Originator Beijing Tiantan Biological Products Company
  • Developer Beijing Center for Disease Control and Prevention; Beijing Tiantan Biological Products Company
  • Class Meningococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections

Most Recent Events

  • 01 Jul 2016 Phase-III clinical trials in Meningococcal group A infections (In children, In volunteers, In adolescents, In adults, Prevention) in China (Parenteral) (NCT02869672)
  • 01 Jul 2016 Phase-III clinical trials in Meningococcal group C infections (In adults, In children, In adolescents, In volunteers, Prevention) in China (Parenteral) (NCT02869672)
  • 01 Jul 2016 Phase-III clinical trials in Meningococcal group W-135 infections (In adults, In adolescents, In children, In volunteers, Prevention) in China (Parenteral) (NCT02869672)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top